Steven E Oliver

Steven E Oliver

UNVERIFIED PROFILE

Are you Steven E Oliver?   Register this Author

Register author
Steven E Oliver

Steven E Oliver

Publications by authors named "Steven E Oliver"

Are you Steven E Oliver?   Register this Author

16Publications

348Reads

23Profile Views

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.

Int J Cancer 2019 Dec 4;145(12):3244-3256. Epub 2019 Apr 4.

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32276DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745281PMC
December 2019

Risk of mature B-cell neoplasms and precursor conditions after joint replacement: a report from the Haematological Malignancy Research Network.

Int J Cancer 2019 Nov 1. Epub 2019 Nov 1.

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32765DOI Listing
November 2019

Time intervals from first symptom to diagnosis for head and neck cancers: An analysis of linked patient reports and medical records from the UK.

Cancer Epidemiol 2019 04 19;59:37-45. Epub 2019 Jan 19.

Hull York Medical School, Allam Medical Building, University of Hull, Hull, HU6 7RX, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2019.01.008DOI Listing
April 2019

Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).

Leuk Lymphoma 2015 11;56(9):2660-7. Epub 2015 Mar 11.

e Department of Health Sciences and the Hull York Medical School , University of York , York , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.1003060DOI Listing
August 2016

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.

Urology 2004 Aug;64(2):317-22

Department of Health Sciences, University of York and Hull York Medical School, York, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2004.03.018DOI Listing
August 2004

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study.

Int J Cancer 2004 Mar;108(6):887-92

Department of Health Sciences, University of York and the Hull York Medical School, Seebohm Rowntree Building, Heslington, York YO10 5DD, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.11631DOI Listing
March 2004

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.

Cancer Epidemiol Biomarkers Prev 2004 Jan;13(1):163-5

Department of Health Sciences, University of York, and The Hull York Medical School, Heslington, York, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.epi-03-0102DOI Listing
January 2004